Thomas Gibbs is Senior Vice President and Chief Commercial Officer of Sunovion Pharmaceuticals Inc., a global biopharmaceutical company focused on the innovative application of science and medicine to help people with serious medical conditions.
A member of the Executive Leadership Team, Mr. Gibbs is responsible for guiding strategy and tactical plans for all marketed products and preparing for the commercialization of Sunovion’s future therapeutics. He oversees all sales, marketing, market access, commercial operations and customer service functions in the U.S., Canada and Europe for the company’s product franchises.
Mr. Gibbs joined Sunovion in November 2019 with 25 years of commercial leadership experience in the pharmaceutical industry. Previously as Executive Vice President and Chief Commercial Officer of Optinose, he designed and deployed an innovative commercial model and channel strategy to support a major product launch. He was also instrumental in designing a novel patient experience program. At Takeda Pharmaceuticals, Mr. Gibbs served as Head of General Medicines in the U.S., responsible for 11 marketed products to treat central nervous system (CNS), metabolic and other disorders. His prior experience includes serving in global and executive leadership roles in commercial operations, sales and marketing at Bristol-Myers Squibb, Novartis and Johnson & Johnson.
A graduate of the Wharton School of the University of Pennsylvania, Mr. Gibbs holds a B.S in Marketing and Finance and an MBA from the Wharton School of Business.